Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard A Burris

Showing results (51-60 of 247) with videos related to

Pageof 25
Sort By:
Cancer|March 9, 2010
Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research ConsortiumJohn D Hainsworth, David R Spigel, Howard A Burris, et al.
Breast Cancer Research and Treatment|April 15, 2018
Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2Sunil Verma, Joyce O'Shaughnessy, Howard A Burris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2010
Lack of correlation between epidermal growth factor receptor status and response to Panitumumab monotherapy in metastatic colorectal cancerJ Randolph Hecht, Edith Mitchell, Marcus A Neubauer, et al.
Clinical Breast Cancer|March 21, 2009
Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients with HER2-positive metastatic breast cancerJeffrey R Infante, Denise A Yardley, Howard A Burris, et al.
Cancer Investigation|March 10, 2010
Phase II study of capecitabine in combination with thalidomide in patients with metastatic breast cancerHoward A Burris, Suzanne F Jones, Dianna Shipley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumabDavid R Spigel, John D Hainsworth, Denise A Yardley, et al.
Clinical Breast Cancer|July 31, 2010
A phase II trial of dose-dense neoadjuvant gemcitabine, epirubicin, and albumin-bound paclitaxel with pegfilgrastim in the treatment of patients with locally advanced breast cancerDenise A Yardley, John Zubkus, Brooke Daniel, et al.
Cancer Investigation|April 28, 2012
Phase 1 results from a study of romidepsin in combination with gemcitabine in patients with advanced solid tumorsSuzanne F Jones, Jeffrey R Infante, David R Spigel, et al.
Journal of Oncology Practice|September 3, 2010
Pegfilgrastim on the Same Day Versus Next Day of Chemotherapy in Patients With Breast Cancer, Non-Small-Cell Lung Cancer, Ovarian Cancer, and Non-Hodgkin's Lymphoma: Results of Four Multicenter, Double-Blind, Randomized Phase II StudiesHoward A Burris, Chandra P Belani, Peter A Kaufman, et al.
Cancer|May 30, 2002
Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research NetworkJohn D Hainsworth, Lisa H Morrissey, Daniel C Scullin, et al.
Pageof 25

Showing results (51-60 of 247) with videos related to

Sort By:
Pageof 25
Cancer|March 9, 2010
Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research ConsortiumJohn D Hainsworth, David R Spigel, Howard A Burris, et al.
Breast Cancer Research and Treatment|April 15, 2018
Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2Sunil Verma, Joyce O'Shaughnessy, Howard A Burris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2010
Lack of correlation between epidermal growth factor receptor status and response to Panitumumab monotherapy in metastatic colorectal cancerJ Randolph Hecht, Edith Mitchell, Marcus A Neubauer, et al.
Clinical Breast Cancer|March 21, 2009
Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients with HER2-positive metastatic breast cancerJeffrey R Infante, Denise A Yardley, Howard A Burris, et al.
Cancer Investigation|March 10, 2010
Phase II study of capecitabine in combination with thalidomide in patients with metastatic breast cancerHoward A Burris, Suzanne F Jones, Dianna Shipley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumabDavid R Spigel, John D Hainsworth, Denise A Yardley, et al.
Clinical Breast Cancer|July 31, 2010
A phase II trial of dose-dense neoadjuvant gemcitabine, epirubicin, and albumin-bound paclitaxel with pegfilgrastim in the treatment of patients with locally advanced breast cancerDenise A Yardley, John Zubkus, Brooke Daniel, et al.
Cancer Investigation|April 28, 2012
Phase 1 results from a study of romidepsin in combination with gemcitabine in patients with advanced solid tumorsSuzanne F Jones, Jeffrey R Infante, David R Spigel, et al.
Journal of Oncology Practice|September 3, 2010
Pegfilgrastim on the Same Day Versus Next Day of Chemotherapy in Patients With Breast Cancer, Non-Small-Cell Lung Cancer, Ovarian Cancer, and Non-Hodgkin's Lymphoma: Results of Four Multicenter, Double-Blind, Randomized Phase II StudiesHoward A Burris, Chandra P Belani, Peter A Kaufman, et al.
Cancer|May 30, 2002
Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research NetworkJohn D Hainsworth, Lisa H Morrissey, Daniel C Scullin, et al.
Pageof 25